Greenwich Lifesciences Stock Price History
| GLSI Stock | USD 11.70 0.52 4.26% |
Below is the normalized historical share price chart for Greenwich Lifesciences extending back to September 25, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Greenwich Lifesciences stands at 11.70, as last reported on the 4th of March, with the highest price reaching 12.25 and the lowest price hitting 11.70 during the day.
If you're considering investing in Greenwich Stock, it is important to understand the factors that can impact its price. Greenwich Lifesciences holds Efficiency (Sharpe) Ratio of -0.0789, which attests that the entity had a -0.0789 % return per unit of risk over the last 3 months. Greenwich Lifesciences exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Greenwich Lifesciences' Risk Adjusted Performance of (0.03), standard deviation of 3.1, and Market Risk Adjusted Performance of (0.14) to validate the risk estimate we provide.
As of now, Greenwich Lifesciences' Stock Based Compensation is increasing as compared to previous years. Sale Purchase Of Stock is expected to grow at the current pace this year, while Common Stock Shares Outstanding is projected to decrease to under 13.8 M. . As of now, Greenwich Lifesciences' Price Book Value Ratio is increasing as compared to previous years. The Greenwich Lifesciences' current Price To Book Ratio is estimated to increase to 19.06, while Price Earnings Ratio is projected to decrease to (14.36). Greenwich Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of September 2020 | 200 Day MA 13.8841 | 50 Day MA 12.43 | Beta 3.32 |
Greenwich |
Sharpe Ratio = -0.0789
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GLSI |
Estimated Market Risk
| 3.04 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Greenwich Lifesciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Greenwich Lifesciences by adding Greenwich Lifesciences to a well-diversified portfolio.
Greenwich Lifesciences Stock Price History Chart
There are several ways to analyze Greenwich Stock price data. The simplest method is using a basic Greenwich candlestick price chart, which shows Greenwich Lifesciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 2, 2024 | 14.95 |
| Lowest Price | December 30, 2024 | 10.91 |
Greenwich Lifesciences March 4, 2025 Stock Price Synopsis
Various analyses of Greenwich Lifesciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Greenwich Stock. It can be used to describe the percentage change in the price of Greenwich Lifesciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Greenwich Stock.| Greenwich Lifesciences Price Rate Of Daily Change | 0.96 | |
| Greenwich Lifesciences Price Daily Balance Of Power | (0.95) | |
| Greenwich Lifesciences Price Action Indicator | (0.54) | |
| Greenwich Lifesciences Accumulation Distribution | 975.27 |
Greenwich Lifesciences March 4, 2025 Stock Price Analysis
Greenwich Stock Price History Data
The price series of Greenwich Lifesciences for the period between Wed, Dec 4, 2024 and Tue, Mar 4, 2025 has a statistical range of 4.04 with a coefficient of variation of 6.52. Under current investment horizon, the daily prices are spread out with arithmetic mean of 12.74. The median price for the last 90 days is 12.68.| Open | High | Low | Close | Volume | ||
| 03/03/2025 | 12.18 | 12.25 | 11.70 | 11.70 | 21,722 | |
| 02/28/2025 | 11.55 | 12.22 | 11.52 | 12.22 | 18,425 | |
| 02/27/2025 | 11.63 | 11.90 | 11.54 | 11.54 | 13,832 | |
| 02/26/2025 | 11.59 | 11.80 | 11.54 | 11.76 | 11,840 | |
| 02/25/2025 | 11.73 | 11.86 | 11.53 | 11.57 | 20,691 | |
| 02/24/2025 | 11.81 | 12.14 | 11.66 | 11.85 | 13,613 | |
| 02/21/2025 | 12.21 | 12.40 | 11.95 | 11.95 | 21,061 | |
| 02/20/2025 | 12.61 | 12.72 | 11.87 | 12.04 | 24,800 | |
| 02/19/2025 | 12.52 | 12.84 | 12.02 | 12.59 | 18,870 | |
| 02/18/2025 | 12.41 | 12.75 | 12.20 | 12.53 | 23,000 | |
| 02/14/2025 | 12.43 | 12.48 | 12.15 | 12.38 | 14,862 | |
| 02/13/2025 | 11.90 | 12.47 | 11.75 | 12.30 | 21,699 | |
| 02/12/2025 | 11.85 | 12.15 | 11.58 | 11.97 | 40,160 | |
| 02/11/2025 | 12.04 | 12.50 | 11.86 | 12.01 | 18,900 | |
| 02/10/2025 | 12.40 | 13.00 | 12.21 | 12.23 | 20,201 | |
| 02/07/2025 | 12.40 | 12.45 | 12.10 | 12.40 | 23,415 | |
| 02/06/2025 | 12.79 | 12.94 | 12.28 | 12.49 | 13,873 | |
| 02/05/2025 | 12.94 | 13.00 | 12.53 | 12.78 | 16,689 | |
| 02/04/2025 | 12.82 | 13.05 | 12.62 | 12.68 | 20,200 | |
| 02/03/2025 | 12.70 | 13.00 | 12.47 | 12.98 | 24,200 | |
| 01/31/2025 | 13.11 | 13.60 | 12.90 | 12.94 | 30,200 | |
| 01/30/2025 | 13.50 | 13.50 | 12.71 | 13.19 | 27,700 | |
| 01/29/2025 | 13.12 | 13.43 | 13.10 | 13.25 | 16,200 | |
| 01/28/2025 | 13.44 | 13.68 | 13.10 | 13.13 | 17,900 | |
| 01/27/2025 | 12.93 | 14.41 | 12.93 | 13.28 | 77,400 | |
| 01/24/2025 | 13.00 | 13.21 | 12.56 | 13.09 | 30,200 | |
| 01/23/2025 | 12.59 | 13.10 | 12.59 | 13.00 | 48,831 | |
| 01/22/2025 | 12.63 | 13.31 | 12.44 | 12.71 | 42,961 | |
| 01/21/2025 | 12.90 | 12.99 | 12.03 | 12.16 | 46,824 | |
| 01/17/2025 | 12.71 | 13.10 | 12.63 | 12.87 | 34,814 | |
| 01/16/2025 | 12.36 | 12.75 | 12.26 | 12.57 | 16,421 | |
| 01/15/2025 | 12.15 | 12.57 | 12.05 | 12.47 | 30,665 | |
| 01/14/2025 | 12.55 | 12.84 | 11.91 | 12.06 | 30,974 | |
| 01/13/2025 | 12.17 | 12.72 | 11.50 | 12.26 | 92,647 | |
| 01/10/2025 | 13.25 | 13.31 | 12.27 | 12.38 | 73,302 | |
| 01/08/2025 | 13.80 | 13.95 | 13.03 | 13.35 | 34,114 | |
| 01/07/2025 | 13.50 | 14.47 | 13.25 | 13.81 | 68,534 | |
| 01/06/2025 | 12.96 | 13.50 | 12.95 | 13.11 | 44,260 | |
| 01/03/2025 | 12.02 | 13.42 | 11.90 | 12.88 | 50,166 | |
| 01/02/2025 | 11.63 | 12.40 | 11.63 | 11.74 | 35,380 | |
| 12/31/2024 | 10.95 | 11.76 | 10.77 | 11.23 | 42,371 | |
| 12/30/2024 | 11.38 | 11.48 | 10.52 | 10.91 | 42,695 | |
| 12/27/2024 | 11.73 | 12.17 | 11.10 | 11.50 | 28,532 | |
| 12/26/2024 | 12.20 | 12.45 | 11.73 | 11.87 | 53,800 | |
| 12/24/2024 | 12.23 | 12.31 | 11.82 | 12.21 | 10,007 | |
| 12/23/2024 | 12.76 | 12.76 | 12.00 | 12.16 | 25,891 | |
| 12/20/2024 | 12.41 | 12.77 | 12.15 | 12.39 | 72,646 | |
| 12/19/2024 | 12.40 | 12.95 | 12.22 | 12.52 | 29,781 | |
| 12/18/2024 | 13.02 | 13.25 | 12.20 | 12.28 | 42,468 | |
| 12/17/2024 | 12.81 | 13.15 | 12.71 | 13.01 | 19,778 | |
| 12/16/2024 | 13.21 | 13.65 | 12.90 | 12.90 | 31,541 | |
| 12/13/2024 | 13.26 | 13.73 | 13.20 | 13.51 | 25,916 | |
| 12/12/2024 | 13.21 | 13.56 | 13.21 | 13.21 | 19,975 | |
| 12/11/2024 | 13.27 | 13.70 | 13.12 | 13.33 | 23,652 | |
| 12/10/2024 | 13.45 | 13.64 | 13.11 | 13.27 | 27,255 | |
| 12/09/2024 | 13.96 | 14.03 | 13.25 | 13.47 | 22,412 | |
| 12/06/2024 | 13.47 | 14.18 | 13.47 | 13.66 | 22,249 | |
| 12/05/2024 | 13.70 | 14.06 | 13.08 | 13.48 | 42,825 | |
| 12/04/2024 | 14.04 | 14.32 | 13.65 | 13.85 | 24,925 | |
| 12/03/2024 | 14.90 | 15.39 | 13.94 | 14.09 | 43,499 | |
| 12/02/2024 | 14.26 | 15.47 | 13.94 | 14.95 | 76,349 |
About Greenwich Lifesciences Stock history
Greenwich Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Greenwich is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Greenwich Lifesciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Greenwich Lifesciences stock prices may prove useful in developing a viable investing in Greenwich Lifesciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.8 M | 13.8 M | |
| Net Loss | -4.1 M | -4.3 M |
Greenwich Lifesciences Stock Technical Analysis
Greenwich Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Greenwich Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Greenwich Lifesciences' price direction in advance. Along with the technical and fundamental analysis of Greenwich Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Greenwich to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | 0.0655 | |||
| Treynor Ratio | (0.15) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Greenwich Stock analysis
When running Greenwich Lifesciences' price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |